Jw Holdings
JW Holdings Corporation, together with its subsidiaries, operates as a healthcare company in South Korea, the United States, Japan, China, and internationally. The company offers amino acid solutions, gastrointestinal agents, wound care, eye care, liver disease treatment, cold medicine, API, oral and topical analgesic, and other miscellaneous pharmaceutical products. It also offers hairdye, hair … Read more
Jw Holdings (096760) - Total Liabilities
Latest total liabilities as of September 2025: ₩662.18 Billion KRW
Based on the latest financial reports, Jw Holdings (096760) has total liabilities worth ₩662.18 Billion KRW as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Jw Holdings - Total Liabilities Trend (2007–2024)
This chart illustrates how Jw Holdings's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Jw Holdings Competitors by Total Liabilities
The table below lists competitors of Jw Holdings ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Wheels India Limited
NSE:WHEELS
|
India | ₹23.31 Billion |
|
Ancom Berhad
KLSE:4758
|
Malaysia | RM575.01 Million |
|
Salmones Camanchaca S.A
SN:SALMOCAM
|
Chile | CL$224.23 Million |
|
Borosil Limited
NSE:BOROLTD
|
India | ₹3.28 Billion |
|
Hansae Co
KO:105630
|
Korea | ₩825.57 Billion |
|
457550
KQ:457550
|
Korea | ₩6.25 Billion |
|
Tavia Acquisition Corp. Unit
NASDAQ:TAVIU
|
USA | $1.36 Million |
|
Bionet
TWO:1784
|
Taiwan | NT$855.33 Million |
Liability Composition Analysis (2007–2024)
This chart breaks down Jw Holdings's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.88 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.66 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.54 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Jw Holdings's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Jw Holdings (2007–2024)
The table below shows the annual total liabilities of Jw Holdings from 2007 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩729.21 Billion | -11.88% |
| 2023-12-31 | ₩827.51 Billion | +0.39% |
| 2022-12-31 | ₩824.32 Billion | +8.33% |
| 2021-12-31 | ₩760.96 Billion | -2.91% |
| 2020-12-31 | ₩783.76 Billion | -12.12% |
| 2019-12-31 | ₩891.84 Billion | +1.97% |
| 2018-12-31 | ₩874.64 Billion | -10.44% |
| 2017-12-31 | ₩976.65 Billion | +6.27% |
| 2016-12-31 | ₩919.04 Billion | +13.10% |
| 2015-12-31 | ₩812.56 Billion | -1.40% |
| 2014-12-31 | ₩824.06 Billion | +5.86% |
| 2013-12-31 | ₩778.42 Billion | -10.70% |
| 2012-12-31 | ₩871.67 Billion | +2.77% |
| 2011-12-31 | ₩848.16 Billion | +55.79% |
| 2010-12-31 | ₩544.41 Billion | +11.28% |
| 2009-12-31 | ₩489.21 Billion | +14.27% |
| 2008-12-31 | ₩428.10 Billion | +25.85% |
| 2007-12-31 | ₩340.17 Billion | -- |